Blood Donation (Transmittable Diseases) Act 1985

The Act operates through a small set of linked concepts. Each functions as a legal trigger or constraint in litigation and in operational compliance.

Prescribed action (dictionary)

• Defined narrowly to include actions brought by or on behalf of a person who claims to have contracted a transmittable disease because of blood supplied by the society (or because of involvement in taking, testing, handling, producing, supplying or administering such blood), and actions by dependants of a deceased person who died after contracting such a disease. The definition expressly excludes actions under the Safety, Rehabilitation and Compensation Act 1988 (Cwlth) or the Workers Compensation Act 1951. This is the class of civil litigation the Act addresses; the statutory defences only apply to prescribed actions (dictionary: prescribed action).

Prescribed requirements (s 5)

• Two requirements are set out in s 5 as the conditions to attract the defences in ss 3 and 4: (a) a written declaration from the donor must be obtained before taking blood; and (b) before supplying blood for administration or for preparing blood products, a sample of the blood must be tested using approved equipment and an approved method to ascertain any pathogen capable of causing the relevant transmittable disease and the society must ascertain a negative result. If an approved form for a declaration exists under s 10, it must be used (s 5 note).

Approved instruments/methods and chief health officer approval (dictionary, s 5)

• "Approved" in relation to an instrument or method means approval in writing by the chief health officer for this Act (dictionary: approved). So the technical standards , what precise tests or equipment qualify , are set administratively by the chief health officer.

Certificate and evidentiary effect (s 4(1)(c), s 9)

• For hospitals and doctors to rely on a defence, a certificate must have been attached to the container at administration time that purports to be signed by the person in charge of the testing laboratory and states the samples were tested using approved equipment and method and that the result was negative (s 4(1)(c)(i)-(ii)). Section 9 makes such a certificate evidence of the stated matters and the facts on which they are based.

Negligence carve-out (ss 3(2), 4(2))

• Both the society's and hospitals'/doctors' statutory defences are unavailable where negligence by the relevant actor (society; hospital/body; doctor or person acting for doctor) in relation to taking, testing, processing, handling or administering the blood/blood product is established and a transmittable disease was contracted as a result of that negligence (ss 3(2), 4(2)(a)-(b)). The Act therefore preserves common-law negligence-based claims where the negligence causally produced the infection.

Knowledge/notice trigger and "all reasonable steps" obligation (s 6)

• The defences are also lost if the society (s 6(1)) had reasonable grounds for believing a donor's declaration might be false or the blood might contain a pathogen, and the society did not take "all reasonable steps" to ensure the blood or product was not administered. For hospitals/body or doctor, s 6(2)-(3) operate similarly where they had been informed that the blood or product may contain a pathogen and did not take all reasonable steps to prevent administration. The Act does not define "all reasonable steps" or the process of being "informed"; those are performance standards that will be tested by evidence in litigation.

Donor immunity (s 8)

• Donors are insulated from civil and criminal proceedings arising only because a person contracted a transmittable disease from blood given by the donor, except for prosecutions under Criminal Code sections 337 and 338 for making false or misleading statements or giving false or misleading information (s 8(1)-(2)). The Act thus channels donor accountability toward criminal prosecution for falsity of declarations rather than private suits for infection.

Regulatory and administrative control (s 10, s 11)

• The Minister approves forms, and an approved form for a declaration is a disallowable instrument (s 10(1)-(3)), creating a parliamentary oversight mechanism for the donor declaration form. The Executive can make regulations for the Act (s 11), and the chief health officer approves equipment and methods in writing (dictionary).

Diseases covered (dictionary)

• "Transmittable disease" is defined to include acquired immune deficiency syndrome, hepatitis B, hepatitis C, HTLV‑1/2 infections, syphilis and any other prescribed disease. The list is explicit for several high‑risk pathogens but also allows extension to other diseases by prescription.

Evidentiary and procedural interaction

• The statutory defences and evidentiary provisions reorient civil litigation burdens: if the society and/or the hospital/doctor can show compliance with written declarations, testing by approved equipment and methods with negative results, and the presence of a laboratory certificate attached to the container (where relevant), they gain a statutory defence unless the claimant proves negligence or the relevant actor had notice or reasonable grounds and failed to take all reasonable steps.

These concepts allocate decision rights (chief health officer, Minister, Executive), place operational obligations (obtain declarations, perform approved tests, attach certificates), and create litigation pathways (statutory defences, evidentiary presumptions, carve-outs for negligence and knowledge).

The Act concentrates legal benefits and operational obligations on a small set of actors and defines the class of potential claimants it addresses.

Primary affected parties

• The Australian Red Cross Society (the society): defined in the dictionary as "the society incorporated by royal charter under the name of the Australian Red Cross Society." The society is the statutory focus , the defences in s 3 are drafted to protect it and persons acting for it (employees, unpaid workers, and persons/bodies taking blood on its behalf). The Act therefore directly affects the society’s legal exposure and operational compliance obligations under s 5.
• Donors: defined as "a person who gives blood at premises or a vehicle of the society." Donors are required to give a written declaration (s 5(a)) and enjoy immunity from civil or criminal proceedings arising solely from another person contracting disease from their donated blood, subject to criminal offences for false or misleading statements under specified Criminal Code sections (s 8).
• Laboratories and persons in charge of testing: s 4(1)(c) and s 9 hinge on certificates signed by the person in charge of the laboratory where samples were tested; those persons have responsibilities for accurate testing and for signing certificates that will be admissible as evidence (s 9).

Secondary affected parties

• Hospitals and other bodies where society-supplied blood or derived products are administered: s 4(1)(a) grants them a defence in prescribed actions where certificates are attached or where the society complied with prescribed requirements; s 6(2) conditions that defence on taking "all reasonable steps" if they are informed of potential contamination.
• Doctors and persons acting on behalf of doctors who administer or authorise administration of society-supplied blood or blood products: s 4(1)(b) gives them a similar defence; s 6(3) limits it where they had been informed that the blood or blood product may contain a pathogen and did not take reasonable steps to prevent administration.
• Claimants/prescribed-action plaintiffs: those who claim to have contracted a transmittable disease because of society-supplied blood or blood products (dictionary: prescribed action). The Act alters plaintiffs’ litigation approach by setting statutory defences that defendants can raise and shifting evidentiary dynamics.

Tertiary stakeholders and oversight actors

• Chief health officer: has the administrative authority to approve equipment and methods in writing; those approvals determine whether testing meets the Act's "approved" standard (dictionary).
• Minister: may approve forms for the Act; the donor declaration form is a disallowable instrument requiring parliamentary notice (s 10(1)-(3)).
• Executive: has power to make regulations for the Act (s 11).
• Parliament/Legislative Assembly: oversight through disallowable instruments for declaration forms and through the regulation-making and disallowance processes referenced in s 10(3) and s 11 notes.

Who bears legal risk and compliance costs

• The society bears a concentrated legal exposure to prescribed actions brought by claimants who allege infection from society-supplied blood. The Act reduces that exposure if the society follows the statutory regime (s 3, s 5), but it also shifts operational costs and recordkeeping responsibilities onto the society (testing, donor declarations, ensuring certificates where required).
• Hospitals and doctors bear operational and legal risk when administering society-supplied blood. They can rely on certificates, but if they are informed or have reason to suspect contamination they must take "all reasonable steps" to avoid administering it or risk losing the statutory defence (s 6(2)-(3)).
• Donors bear the obligation to provide truthful declarations. The Act limits donors' civil exposure but preserves criminal liability for false statements or giving false information (s 8 referencing Criminal Code ss 337-338 and the s 5 note referencing Criminal Code pt 3.4).

Excluded or unaffected groups

• Suppliers of blood other than the society are not protected by the Act’s statutory defences unless they fall within the defined "society" or operate under contract for it; the Act explicitly refers to the society (s 3, s 4, dictionary).
• Workers’ compensation and certain federal statutory compensation regimes are excluded from the prescribed-action definition (dictionary: prescribed action excludes actions under the Safety, Rehabilitation and Compensation Act 1988 (Cwlth) or the Workers Compensation Act 1951). Therefore, claims under those statutes are not controlled by the Act’s defences.

Geographic and procedural reach

• The Act is an Australian Capital Territory enactment. Its applicability is to activities involving the society in the ACT , the definitions link donors to giving blood “at premises or a vehicle of the society,” and the administrative instruments (Ministerial approvals, chief health officer approvals, regulations) are territory-based.

In short, the Act primarily affects the society and its operational partners (labs, hospitals, doctors), allocates administrative approval power to the chief health officer and Minister, and changes the legal exposure of donors and claimants through immunities and statutory defences.

This section distils the obligations the Act places on different actors and the specific rights or defences it creates.

Duties on the society (operative duties)

• Obtain a written donor declaration before taking blood (s 5(a)). If an approved form exists under s 10, that form must be used (s 5 note).
• Test a sample of the blood using "approved equipment" and "an approved method" and ascertain a negative result before supplying the blood for administration or for use in producing blood products (s 5(b)). "Approved" is a technical approval in writing by the chief health officer (dictionary).
• Where the society has reasonable grounds to believe that a donor's declaration may be false or that the blood may contain a pathogen after taking the blood intended for supply, the society must take "all reasonable steps" to ensure the blood or blood product is not administered; failure to do so removes the s 3 statutory defence (s 6(1)).

Duties on laboratories and the person in charge

• Ensure testing is performed with approved equipment and methods and produce accurate results that can be certified. If a certificate is attached to the container purporting to be signed by the person in charge of the laboratory, the certificate is admissible evidence of those facts (s 9). While s 9 grants evidentiary status to such certificates, it also places practical responsibility on laboratory signatories to ensure the certificate's truth.

Duties on hospitals, other administering bodies and doctors

• If relying on the statutory defence in s 4, ensure at the time of administration that a certificate is attached to the container stating the sample(s) were tested with approved equipment and an approved method and that the result was negative (s 4(1)(c)), or rely on the society having complied with prescribed requirements (s 4(1)(d)).
• If informed that a unit of blood or blood product may contain a pathogen, the hospital/other body must take "all reasonable steps" to prevent administration; failure removes the s 4 defence (s 6(2)). The same applies to a doctor or person acting for a doctor who, at the time the blood was administered, had been informed that it may contain a pathogen (s 6(3)).

Donor obligations and rights

• Provide a written declaration truthful as to the matters required by the declaration form; making false or misleading statements is an offence under the Criminal Code , the Act explicitly references this point in s 5 note and in s 8 which preserves criminal liability for such false statements (s 8(2)). The Act makes it an offence under the Criminal Code to make false or misleading statements or give false or misleading information (s 5 note).
• Donors have a statutory protection from civil or criminal proceedings arising only because a recipient contracted a transmittable disease from their donated blood, except for the Criminal Code offences mentioned (s 8(1)-(2)). That is a right of immunity against private suits.

Statutory defences (rights) for society, hospitals, doctors

• The society has a defence in a prescribed action if it complied with prescribed requirements or caused them to be complied with in respect of taking and testing the blood and handling the products (s 3(1)). This defence is disapplied where negligence is established and caused the disease (s 3(2)).
• Hospitals and doctors have parallel defences where a certificate is attached at administration attesting to approved testing and negative results, or where the society complied with the prescribed requirements (s 4(1)(c)-(d)). Those defences are eliminated by negligence by the hospital/doctor or the society (s 4(2)).

Evidentiary privileges and burden-shifting

• A laboratory certificate is made evidence of the matters it states and the facts on which they are based (s 9). Practically, that shifts evidentiary burdens: certificates will be admissible proof of testing and negative results, placing the onus on the claimant to show the certificate is false, forged, the testing was defective despite appearances, or that negligence or notice exceptions apply.

Administrative rights and controls

• The Minister may approve forms and the approved donor declaration is a disallowable instrument (s 10(1)-(3)), which gives the Legislative Assembly a mechanism to disallow the form. The chief health officer has the right to approve equipment and methods in writing (dictionary: approved). The Executive may make regulations for the Act (s 11).

Exceptions and carve-outs

• Negligence carve-out: defences are not available where negligence by the society, hospital, doctor or agent is established and a transmittable disease was contracted as a result (ss 3(2), 4(2)).
• Knowledge/notice carve-out: defences are not available where the society or administering body had reasonable grounds for believing a declaration may be false or the blood may contain a pathogen and they did not take all reasonable steps to prevent administration (s 6). For hospitals and doctors, the trigger is being informed that the blood or product may contain a pathogen (s 6(2)-(3)).

Other procedural duties

• Use of approved forms: if the Minister approves a form for a purpose (for example, the donor declaration), that approved form must be used (s 10(2)).
• The disclosure and recordkeeping implied by attaching certificates to containers and obtaining written declarations imposes documentary duties on the society and the laboratory personnel.

In summary, the Act creates procedural and technical compliance duties (written donor declarations, approved testing and certified negative results), administrative oversight by the chief health officer and Minister, statutory defences for society and administering parties, explicit carve-outs for negligence and knowledge, and donor immunities subject to criminal offence exceptions.

The Act primarily operates by creating civil defences and evidentiary rules rather than by creating a standalone criminal enforcement regime. Nevertheless it interacts with criminal law and administrative oversight, and republication material supplies penalty unit values as of 12 April 2007.

Penalties explicitly referenced in the Act and republished material

• The Act itself does not prescribe criminal penalties for breaches of the procedural requirements in ss 3-6; it focuses on civil defences. However, s 5 contains a note stating it is an offence to make a false or misleading statement or give false or misleading information under the Criminal Code, part 3.4; and s 8(2) preserves donor criminal liability where a donor has been found guilty under Criminal Code ss 337 or 338. These references mean that the criminal enforcement mechanism for false donor declarations lies in the Criminal Code, not in this Act.
• The republication cover material sets penalty unit values as at 12 April 2007: individuals $100; corporations $500. Those penalty unit values are relevant where offences in other statutes (for example the Criminal Code offences referenced) use penalty units. The Act itself does not specify an internal schedule of penalties.

Civil enforcement mechanics

• The Act provides statutory defences in prescribed actions (ss 3-4). Enforcement in the civil sphere takes place through ordinary civil litigation: claimants bring prescribed actions and defendants (society, hospitals, doctors) raise the statutory defences. The Act alters the litigation structure by placing evidentiary weight on certificates (s 9) and by specifying the circumstances under which the defences are not available (ss 3(2), 4(2), 6).
• The evidentiary certificate (s 9) simplifies proof for defendants: a certificate purporting to be signed by the person in charge of the laboratory that states approved testing and negative results is "evidence of the matters so stated and of the facts on which they are based." It does not on its face make the matters conclusive, but it creates a strong evidentiary presumption that plaintiffs must rebut (s 9).

Administrative oversight and instrument control

• The Minister’s approval of donor declaration forms is a disallowable instrument (s 10(3)). Disallowable instruments are subject to parliamentary scrutiny and disallowance under the Legislation Act 2001. This provides a non‑criminal administrative enforcement and oversight mechanism for the form used to satisfy s 5(a).
• The chief health officer’s power to approve equipment and methods in writing (dictionary: approved) concentrates technical quality control with an administrative official. Enforcement of standards set by the chief health officer will be administrative and scientific rather than criminal under this Act; failure to use approved methods may remove the statutory defence in litigation but does not in itself create a new statutory offence in this Act.

How loss of statutory defence occurs (practical enforcement triggers)

• A claimant can succeed against a defendant despite the presence of certificates or apparent compliance if the claimant proves: negligence by the society or administering actor caused the infection (ss 3(2), 4(2)) or that the society/hospital/doctor had reasonable grounds/was informed that blood may contain a pathogen and did not take all reasonable steps to prevent administration (s 6).
• The Act therefore enforces compliance indirectly via civil liability risk: the practical exposure to damages in the absence of compliance or where negligence is proved acts as the enforcement mechanism.

Limitations and omissions as to enforcement

• The Act does not set out inspection powers, criminal sanctions for failing to obtain a declaration or to carry out approved testing, or administrative penalties beyond instrument oversight. It relies on civil litigation, criminal provisions in other statutes for false declarations, and administrative approvals to produce compliance incentives.

Practical enforcement considerations

• Because the evidentiary certificate is admissible and because compliance with approved methods and forms is an express statutory condition of the defences, defendants have clear tactical incentives to document testing and use approved forms. Plaintiffs have incentives to dispute certificates, present evidence of negligent testing/handling, or show the defendant had notice/reasonable grounds and failed to act on them.
• The absence of standalone criminal sanctions in the Act for procedural non‑compliance means that administrative oversight and civil litigation will be the principal enforcement levers. The Minister’s disallowable instrument power over the donor form and the chief health officer’s approval power over equipment and methods are the main non‑litigious levers available under the Act.

The Act is framed to operate alongside, and not replace, a network of other laws and administrative instruments. The text and endnotes show explicit interactions with several statutory regimes and administrative instruments.

Interaction with the Criminal Code

• The Act references criminal offences for false or misleading statements or information. Section 5 includes a note that it is an offence to make a false or misleading statement or give false or misleading information (see Criminal Code, pt 3.4). Section 8 limits donor immunity where the donor has been found guilty of an offence under Criminal Code s 337 (Making false or misleading statements) or s 338 (Giving false or misleading information). Thus, the criminal enforcement path for false donor declarations is provided by the Criminal Code; the Act does not create duplicate criminal penalties (s 5 note; s 8(2)).

Exclusion of certain compensation regimes

• The dictionary's definition of "prescribed action" excludes actions brought under the Safety, Rehabilitation and Compensation Act 1988 (Cwlth) and the Workers Compensation Act 1951. This means workers’ compensation and certain federal rehabilitation/compensation pathways operate in parallel or outside the remedial reach of this Act; claimants who pursue those statutory schemes are outside the Act’s prescribed-action definition and the Act’s defences will not be the controlling regime for those claims (dictionary: prescribed action).

Administrative instrument frameworks (Legislation Act)

• The Act makes the donor declaration an approved form that is a disallowable instrument (s 10(3)). The disallowable/instrument framework and notifiable instruments are governed by the Legislation Act 2001, which requires notification and presentation to the Legislative Assembly. The Act therefore interacts procedurally with the Legislation Act: ministerial approvals carry parliamentary notice and potential disallowance (s 10 notes).

Health administration and technical standards

• The Act vests technical standard-setting in the chief health officer by defining "approved" as approval in writing by the chief health officer for this Act (dictionary: approved). This places the Act within the administrative public health regime: the chief health officer’s determinations about equipment and methods will be central to compliance and to litigation over whether testing complied with the Act. The Act itself does not specify what methods or equipment are approved; that is delegated administratively.

Common-law and civil liability

• The statutory defences operate within the existing common-law framework for negligence. The Act preserves negligence-based liability: the defences are not available if negligence is established and was causative of the disease (ss 3(2), 4(2)). Accordingly, ordinary tort principles of duty, breach, causation and damages remain the judicial means to test whether negligence occurred.

Interplay with other public health or regulatory statutes

• The definition of "transmittable disease" includes "any other prescribed disease," which implicitly allows extension of coverage by subordinate instruments (dictionary). That creates an interface with public health regulation: the set of diseases to which the Act applies may be expanded administratively, subject to the procedures that govern prescribing diseases under the relevant legislative framework.

Legislative history and conversions

• The endnotes show that this Act originated as a Commonwealth ordinance and was converted to an ACT enactment following self-government (endnotes 3 and 4), reflecting its historical interaction with Commonwealth law and the process by which the ACT Legislative Assembly became competent to amend or repeal the prior ordinance. The amendment history illustrates other statutory interactions, such as consequential amendments by Health Services Acts and statutory law revision acts (endnotes 3-4).

Practical implications of interactions

• Because the chief health officer and the Minister are given administrative powers, compliance decisions will be shaped by administrative law principles and by the content of the approved forms and approvals. Civil litigation will turn on whether approved methods/equipment were used and whether appropriate forms and certificates were in place; criminal prosecution for false declarations will require reference to the Criminal Code. Compensation via workers’ compensation or certain federal schemes is explicitly excluded from the Act’s prescribed-action coverage.

In sum, the Act is embedded in a regulatory and legal ecosystem: it relies on the Criminal Code for sanctions against false declarations, the Legislation Act for oversight of approved forms, the chief health officer for technical approvals, and the common law for negligence-based claims, while excluding certain statutory compensation regimes from its scope.

The Act’s endnotes set out a compact legislative history. Below are the principal changes and their legal mechanics, as derived from the republished endnotes and the Act text itself.

Origin and early Commonwealth ordinances

• The Act began as a Commonwealth ordinance, the Blood Donation (Acquired Immune Deficiency Syndrome) Ordinance 1985 (Ord1985-27), notified and commenced 1 July 1985 (endnote 3). It was amended by two Commonwealth ordinances in 1985 and 1986 (Ord1985-55; Ord1986-47; Ord1986-90), which inserted various provisions and requirements (endnote 3 and 5).

Conversion to ACT enactment and citation changes

• The Australian Capital Territory (Self-Government) Act 1988 converted former Commonwealth ordinances in force in the ACT into ACT enactments on 11 May 1989 (self-government day). The ordinance was converted into an ACT enactment at that time (endnote 3). The Self-Government (Citation of Laws) Act 1989 changed the name from "Ordinance" to "Act" on 11 May 1989 (endnote 3).

1990s amendments and renaming

• The Health Services (Consequential Provisions) Act 1990 and related consequential amendments adjusted definitions (endnotes 3 and 4). The Blood Donation (Transmittable Diseases) (Amendment) Act 1996 A1996-78 effected a renaming and important substantive amendments: the Act’s title was changed and the definition of "transmittable disease" was inserted (endnotes 3 and 4; dictionary). The 1996 amendments also updated s 3 and introduced other structural changes (endnote 4: s 3 am Ord1986-47 s 4; A1996-78 s 7).

2000s amendments and editorial changes

• The Legislation (Consequential Amendments) Act 2001 A2001-44 made amendments that commenced in part on 12 September 2001, including introducing s 10 (approved forms) and s 11 (regulation-making power) as indicated in the amendment history (endnotes 3-4 and the Act text; s 10 inserted Ord1986-47 s 7; s 11 ins A2001-44 amdt 1.370).
• The Criminal Code (Theft, Fraud, Bribery and Related Offences) Amendment Act 2004 and Statute Law Amendment Act 2007 A2007-3 made further changes, several of which were editorial relocations of definitions into the dictionary (endnotes 4 and 5). The Statute Law Amendment Act 2007 relocated various definitions (approved, donor, prescribed action, society, transmittable disease) to the dictionary (endnote 4: defs reloc A2007-3 amdt 3.47-3.52).

Omitted provisions and renumbering

• The amendment history and endnotes show that some provisions were omitted or renumbered over time, and that the schedule was omitted by earlier ordinances (endnote 5). For example, the Act had a section 7 noted as amended by A1998-54 sch and later omitted by A2004-15 (endnote 5). The current republished text shows s 7 omitted; the Act makes explicit references to the Criminal Code where necessary (s 5 note; s 8).

Administrative instrumentation changes

• Section 10, introduced in earlier amendments, grants the Minister power to approve forms, and specifies that the approved donor declaration form is a disallowable instrument (s 10(1)-(3)). Section 11, introduced by later amendments, expressly authorises the Executive to make regulations (s 11).

Republication and editorial changes

• The Parliamentary Counsel’s Office republished the Act on 12 April 2007, including editorial changes authorised under the Legislation Act 2001, part 11.3. The republication notes indicate editorial amendments do not change the effect of the law but take effect as if made by an Act commencing on the republication date (endnote 1). The republished Act includes amendment and legislation histories to 12 April 2007.

Chronology highlights (simplified)

• 1985: Original Commonwealth ordinance enacted (Ord1985-27).
• 1985-1986: Early amendments to expand or clarify provisions (Ord1985-55; Ord1986-47; Ord1986-90).
• 1989: Conversion to ACT enactment and citation change coincident with self-government.
• 1990-1996: Health-related consequential amendments; 1996 Act renamed and transmittable disease definition inserted (A1996-78).
• 2001: Legislation Act consequential amendments, insertion of form/regulation provisions (A2001-44).
• 2004-2007: Further amendments, relocations of definitions, and editorial republication (A2004-15; A2007-3).

The endnotes provide the authoritative record of each amendment instrument, notification and commencement dates. Where the republished Act references an omitted provision (for example s 7), the amendment history explains the removal and the amending instrument.

The Act text and endnotes do not record or name judicial decisions. The statute as republished contains no reported cases, and the endnotes list only legislative instruments and amendments. Therefore the Act itself does not provide a litigation history or list of judicial interpretations.

What this implies for litigation practice

• Because the Act creates statutory defences and assigns evidentiary weight to laboratory certificates (s 9), litigation in this field will likely concentrate on a narrow set of factual and legal issues: whether the society complied with the prescribed requirements (s 3, s 5), whether a certificate was properly attached and accurately reflected approved testing and negative results (s 4(1)(c), s 9), whether negligence on the part of the society, hospital or doctor caused the infection (ss 3(2), 4(2)), and whether the knowledge/notice and "all reasonable steps" threshold in s 6 applies.
• Plaintiffs in prescribed actions will need to establish either that the society or administering actor did not comply with the prescribed requirements, that the laboratory certificate was false or unreliable, that negligence occurred and caused the disease, or that the society/hospital/doctor had notice or reasonable grounds to suspect contamination and failed to take reasonable steps (s 6). Defendants will typically rely on documentary proof , donor declaration forms, laboratory test records and certificates , and on demonstrating use of approved equipment and methods (s 5, s 9).
• The Act’s evidentiary provision for certificates (s 9) changes typical discovery and proof dynamics: a properly signed certificate is admissible evidence of technical testing and results, so plaintiffs must often prove falsity, forgery, testing error, chain-of-custody lapse, or negligence in procedures to overcome the presumption that the testing was properly carried out.

Anticipated litigation lines (based on statutory text)

• Plaintiffs will test the authenticity and accuracy of laboratory certificates and whether "approved" equipment and methods were actually used (s 5, s 9, dictionary: approved).
• Plaintiffs will investigate whether the donor declaration was obtained on the approved form and whether it contained false statements (s 5(a), s 10(3)); criminal prosecutions for false statements under the Criminal Code may run in parallel or be a source of evidence.
• Defendants will typically rely on compliance evidence, chain‑of‑custody records, and the s 9 certificate as a central element of their defence.
• Where a defendant had notice (was "informed") that a unit might contain a pathogen, litigation will centre on what "all reasonable steps" were available and whether they were taken (s 6(2)-(3)).

Absence of reported cases in the Act

• The Act itself and the republished endnotes contain no judicial decisions. Practitioners must therefore look beyond this text to case law in the ACT and other jurisdictions for judicial treatment of analogous statutory defences, evidentiary certificates and negligence standards in blood transfusion cases, taking care to note jurisdictional differences and the fact-based nature of such disputes.

Practical pitfalls, ambiguous terms, and procedural risks embedded in the Act that practitioners and compliance officers should watch for are set out below, grounded in the Act’s text.

"Approved" hinges on chief health officer's written approval

• The Act makes use of the term "approved" for equipment and methods, and defines "approved" as approval in writing by the chief health officer for this Act (dictionary: approved). This delegates essential technical standards to an administrative official. If a society or laboratory uses equipment or methods not expressly approved in writing by the chief health officer, the statutory defences may not be available even if testing was otherwise competent (s 5(b)). Practical gotcha: keep the chief health officer's written approvals on file and ensure changes in testing technology are authorised in writing.

Donor declaration form is a disallowable instrument (s 10(3))

• If the Minister approves a particular form for the donor declaration, that form must be used (s 5 note; s 10(1)-(3)). The approved declaration form is a disallowable instrument, meaning it is subject to parliamentary disallowance procedures. Gotcha: using a variant or outdated form may defeat the "must be used" requirement and risk losing the statutory defence.

Certificate attachment and timing (s 4(1)(c); s 9)

• The hospital/doctor defence in s 4(1)(c) requires that "at the time the blood or blood product was administered, there was attached to the container" a certificate purporting to be signed by the person in charge of the laboratory. Gotcha: failure to attach the certificate, attaching an unsigned or improperly signed certificate, or attaching it after administration will risk precluding the statutory defence. Practically, chain-of-custody and record processes must ensure certificates accompany units into the point of administration.

"All reasonable steps" and "informed" are undefined (s 6)

• The Act disapplies the defences where the society had reasonable grounds to believe a declaration might be false or the blood may contain a pathogen and did not take "all reasonable steps" to prevent administration (s 6(1)), or where hospitals/doctors had been "informed" of risk and did not take "all reasonable steps" (s 6(2)-(3)). Neither "all reasonable steps" nor "informed" is defined. Gotcha: these are fact‑intensive standards that invite dispute in litigation; absent policy or guidance under regulations or chief health officer directions, they can create uncertainty in urgent clinical decisions.

Evidence produced by certificate is not necessarily conclusive (s 9)

• Section 9 says a certificate is evidence of the matters stated and the facts on which they are based; it does not say the certificate is conclusive proof. Plaintiffs may still adduce evidence that tests were flawed, equipment was misused, or that the certificate was forged. Gotcha: defendants should retain complete laboratory logs, chain-of-custody, validation records for equipment and personnel training records to rebut challenges.

Scope limited to society-supplied blood (dictionary: prescribed action)

• The Act applies only to prescribed actions involving blood supplied by the society or blood products derived from such blood. Gotcha: other blood suppliers or private collection arrangements fall outside the Act’s protective structure; separate supplier contracts and liability regimes apply.

Donor immunity limited; criminal liability remains (s 8)

• Donors are insulated from civil and criminal proceedings arising solely from another’s infection, but the Act preserves criminal prosecution for false statements under Criminal Code provisions (s 8). Gotcha: donors may still be criminally prosecuted for falsity; organisations should consider the interplay between civil discovery and criminal process.

Regulatory gap: Act does not itself create inspection or mandatory audit powers

• The Act focuses on defences and evidentiary rules rather than on enforcement mechanisms such as inspection, mandatory audits, or offences for failing to obtain declarations or run approved tests. Gotcha: regulators or plaintiffs will need to rely on other statutes or general administrative and civil mechanisms to address systemic non‑compliance.

Penalty unit values may change over time

• The republication notes penalty unit values as at 12 April 2007 (individual $100; corporation $500). Gotcha: penalty unit values are subject to change over time; reliance on these figures for present-day compliance or penalty estimation must be checked against current penalty unit schedules.

Administrative instruments and approvals can be amended or disallowed

• The donor declaration form is a disallowable instrument and the chief health officer's approvals are administrative instruments. Gotcha: these instruments can change; operational procedures must monitor instrument status and any parliamentary action that could disallow a form.

Transmittable disease list includes "any other prescribed disease" (dictionary)

• The dictionary allows extension by prescription to other diseases. Gotcha: the set of diseases covered by the Act can be expanded administratively; organisations must monitor prescriptions to know whether new diseases fall under the statutory scheme.

Absence of emergency exception

• The Act does not explicitly exempt emergency transfusions where obtaining a declaration or attaching a certificate is impracticable. Gotcha: clinical decisions in emergencies may place hospitals and doctors in a position where the statutory defence is not strictly satisfied; however, negligence law and clinical necessity doctrines may also be relevant in litigation. The Act’s silence on this point means clinical protocols and documentation must be robust to justify emergency actions in litigation.

This section is an operational checklist, grounded in the Act, for the society, laboratories, hospitals, doctors and donors. It connects statutory requirements to practical steps and recordkeeping to preserve statutory defences.

For the society (Australian Red Cross Society)

1. Use approved donor declaration form

   • Ensure a written donor declaration is obtained before taking blood (s 5(a)).
   • If the Minister has approved a form for this purpose under s 10, use the approved form without deviation (s 5 note; s 10(2)-(3)). Keep an up-to-date register of the current approved form and ensure all collection centres use it.

2. Obtain and retain donor declarations

   • Keep signed originals or secure electronic copies (if the form permits) and a chain-of-custody trail linking the declaration to the blood unit. Document the time of declaration and the identity of the collection staff.

3. Ensure approved testing

   • Test a sample of each unit intended for supply, using equipment and methods approved in writing by the chief health officer (s 5(b); dictionary: approved).
   • Maintain written proof of the chief health officer’s approvals for the equipment and methods in use, and ensure laboratory validation records and quality assurance logs are retained.

4. Record negative test results and attach certificates where required

   • For blood intended for administration, ascertain the negative test result before release (s 5(b)). Preserve comprehensive laboratory test records, including full instrument run data, lot numbers for reagents, operator IDs, and calibration/maintenance logs.

5. Produce and sign laboratory certificates

   • Ensure the person in charge of the laboratory signs certificates that state testing was done using approved equipment and method and that the result was negative (s 4(1)(c); s 9). Keep signed master copies.

6. Policies for suspect donations

   • If after taking blood the society has reasonable grounds to believe a donor’s declaration may be false or the blood may contain a pathogen, take "all reasonable steps" to ensure the blood is not administered (s 6(1)). Document the grounds for suspicion and the steps taken (segregation, quarantine, destruction, notification).

7. Training and audit

   • Train collection staff and laboratory personnel on the statutory requirements and on the use of approved forms and methods. Conduct periodic audits to ensure ongoing compliance.

For laboratories and the person in charge

1. Maintain approvals and equipment validation

   • Ensure equipment and methods are approved in writing by the chief health officer and that validation and QA documentation is current (dictionary: approved).

2. Accurate certification and retention

   • When signing certificates that will accompany blood containers, confirm that all supporting test data are accurate and retained. Remember s 9: the certificate is admissible evidence of the stated matters.

3. Chain of custody and documentation

   • Implement chain-of-custody procedures linking donor declaration, sample, test result, certificate and the unit container.

For hospitals, other administering bodies and doctors

1. Check for attached certificate at administration

   • At the time of administration, ensure a certificate purporting to be signed by the laboratory person in charge is attached to the container and states testing by approved equipment and method and a negative result (s 4(1)(c)). If relying on the society’s compliance as the basis of your defence, ensure you have contemporaneous documentation of that reliance (s 4(1)(d)).

2. Policies for being informed of potential contamination

   • If the hospital or doctor is "informed" that a blood unit may contain a pathogen, take "all reasonable steps" to prevent administration (s 6(2)-(3)). Establish a clear protocol for what constitutes being "informed" (e.g. receipt of written notice, quarantine tags, internal alerts) and which steps will be taken in response.

3. Emergency procedures

   • Because the Act does not expressly carve out emergencies, document the clinical basis for any emergency administration without a certificate or declaration, including contemporaneous notes explaining why delay would have endangered the patient.

4. Recordkeeping

   • Keep copies of attached certificates, donor declaration references, and any correspondence with the society about the blood unit. Retain these records for an appropriate statutory or clinical retention period.

For donors

1. Use the approved declaration form and be truthful
   • Complete the written declaration truthfully and on the approved form if one is provided (s 5(a); s 10(2)-(3)). Be aware that false or misleading statements may give rise to criminal prosecution under the Criminal Code, which the Act references (s 5 note; s 8(2)).

Cross-cutting compliance measures

1. Monitor administrative instruments

   • Track the chief health officer’s approvals for equipment and methods and the Minister’s approved declaration form (s 10(1)-(3); dictionary). Note disallowable instruments may be disallowed by the Legislative Assembly; maintain a process for updating forms and approvals.

2. Implement a recall and quarantine protocol

   • For any unit where post‑collection information casts doubt on the donor declaration or testing, immediately quarantine the unit, notify receiving hospitals, and document steps taken in accordance with s 6(1).

3. Maintain auditable logs and retention

   • Keep an auditable record linking the donor declaration, test data, certificate, container labelling and chain-of-custody. Given the evidentiary value of certificates (s 9), supporting records are necessary to rebut challenges to certificates or to show compliance.

4. Legal interface with Criminal Code

   • Coordinate with legal counsel regarding referrals to prosecuting authorities for false donor declarations; criminal prosecutions under Criminal Code provisions may run concurrently with civil claims.

5. Internal governance and oversight

   • Develop governance oversight (board-level) for compliance with s 5 requirements, chief health officer approvals, recordkeeping and incident response for suspected contamination, and ensure designated officers are authorised to act in urgent situations.

By following these steps and maintaining contemporaneous documentation of each stage in the collection, testing, processing, certification and administration chain, operators maximise the probability of being able to rely on the statutory defences in ss 3 and 4 and to satisfy the evidentiary presumption in s 9 where appropriate.